Literature DB >> 32979964

Offline: COVID-19 is not a pandemic.

Richard Horton.   

Abstract

Entities:  

Year:  2020        PMID: 32979964      PMCID: PMC7515561          DOI: 10.1016/S0140-6736(20)32000-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
As the world approaches 1 million deaths from COVID-19, we must confront the fact that we are taking a far too narrow approach to managing this outbreak of a new coronavirus. We have viewed the cause of this crisis as an infectious disease. All of our interventions have focused on cutting lines of viral transmission, thereby controlling the spread of the pathogen. The “science” that has guided governments has been driven mostly by epidemic modellers and infectious disease specialists, who understandably frame the present health emergency in centuries-old terms of plague. But what we have learned so far tells us that the story of COVID-19 is not so simple. Two categories of disease are interacting within specific populations—infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and an array of non-communicable diseases (NCDs). These conditions are clustering within social groups according to patterns of inequality deeply embedded in our societies. The aggregation of these diseases on a background of social and economic disparity exacerbates the adverse effects of each separate disease. COVID-19 is not a pandemic. It is a syndemic. The syndemic nature of the threat we face means that a more nuanced approach is needed if we are to protect the health of our communities. The notion of a syndemic was first conceived by Merrill Singer, an American medical anthropologist, in the 1990s. Writing in The Lancet in 2017, together with Emily Mendenhall and colleagues, Singer argued that a syndemic approach reveals biological and social interactions that are important for prognosis, treatment, and health policy. Limiting the harm caused by SARS-CoV-2 will demand far greater attention to NCDs and socioeconomic inequality than has hitherto been admitted. A syndemic is not merely a comorbidity. Syndemics are characterised by biological and social interactions between conditions and states, interactions that increase a person's susceptibility to harm or worsen their health outcomes. In the case of COVID-19, attacking NCDs will be a prerequisite for successful containment. As our recently published NCD Countdown 2030 showed, although premature mortality from NCDs is falling, the pace of change is too slow. The total number of people living with chronic diseases is growing. Addressing COVID-19 means addressing hypertension, obesity, diabetes, cardiovascular and chronic respiratory diseases, and cancer. Paying greater attention to NCDs is not an agenda only for richer nations. NCDs are a neglected cause of ill-health in poorer countries too. In their Lancet Commission, published last week, Gene Bukhman and Ana Mocumbi described an entity they called NCDI Poverty, adding injuries to a range of NCDs—conditions such as snake bites, epilepsy, renal disease, and sickle cell disease. For the poorest billion people in the world today, NCDIs make up over a third of their burden of disease. The Commission described how the availability of affordable, cost-effective interventions over the next decade could avert almost 5 million deaths among the world's poorest people. And that is without considering the reduced risks of dying from COVID-19. The most important consequence of seeing COVID-19 as a syndemic is to underline its social origins. The vulnerability of older citizens; Black, Asian, and minority ethnic communities; and key workers who are commonly poorly paid with fewer welfare protections points to a truth so far barely acknowledged—namely, that no matter how effective a treatment or protective a vaccine, the pursuit of a purely biomedical solution to COVID-19 will fail. Unless governments devise policies and programmes to reverse profound disparities, our societies will never be truly COVID-19 secure. As Singer and colleagues wrote in 2017, “A syndemic approach provides a very different orientation to clinical medicine and public health by showing how an integrated approach to understanding and treating diseases can be far more successful than simply controlling epidemic disease or treating individual patients.” I would add one further advantage. Our societies need hope. The economic crisis that is advancing towards us will not be solved by a drug or a vaccine. Nothing less than national revival is needed. Approaching COVID-19 as a syndemic will invite a larger vision, one encompassing education, employment, housing, food, and environment. Viewing COVID-19 only as a pandemic excludes such a broader but necessary prospectus.
  182 in total

1.  Pulling health promotion and chronic disease prevention from the margins of the global public health agenda-again.

Authors:  Robert Geneau
Journal:  Health Promot Chronic Dis Prev Can       Date:  2021-03       Impact factor: 3.240

2.  The Role of Colombian Psychiatrists in the Midst of the COVID 19 Pandemic.

Authors:  Juan Fernando Cano; Jairo Mario González-Díaz; Alexie Vallejo-Silva; Marcela Alzate-García; Rodrigo Nel Córdoba-Rojas
Journal:  Rev Colomb Psiquiatr       Date:  2021-06-05

3.  The measles outbreak in Israel in 2018-19: lessons for COVID-19 pandemic.

Authors:  Chen Stein-Zamir; Hagai Levine
Journal:  Hum Vaccin Immunother       Date:  2021-01-22       Impact factor: 3.452

4.  COVID-19 and People Who Use Drugs - A Commentary.

Authors:  Suzan M Walters; David W Seal; Thomas J Stopka; Megan E Murphy; Wiley D Jenkins
Journal:  Health Behav Policy Rev       Date:  2020-10

Review 5.  Which ethical values underpin England's National Health Service reset of paediatric and maternity services following COVID-19: a rapid review.

Authors:  Anna Chiumento; Paul Baines; Caroline Redhead; Sara Fovargue; Heather Draper; Lucy Frith
Journal:  BMJ Open       Date:  2021-06-08       Impact factor: 2.692

6.  COVID-19 and non-communicable diseases in the Eastern Mediterranean Region: the need for a syndemics approach to data reporting and healthcare delivery.

Authors:  Ghiwa Nassereddine; Samia Habli; Slim Slama; Kasturi Sen; Anthony Rizk; Abla M Sibai
Journal:  BMJ Glob Health       Date:  2021-06

7.  Should COVID-19 be branded to viral thrombotic fever?

Authors:  Rubens Carmo Costa-Filho; Hugo Caire Castro-Faria Neto; José Mengel; Marcelo Pelajo-Machado; Marco Aurélio Martins; Érica Távora Leite; Hugo Tannus Mendonça-Filho; Tatiana de Arruda Campos Brasil de Souza; Gonzalo Bentacor Bello; José Paulo Gagliardi Leite
Journal:  Mem Inst Oswaldo Cruz       Date:  2021-04-30       Impact factor: 2.743

8.  The relation between the social and the biological and COVID-19.

Authors:  M P Kelly
Journal:  Public Health       Date:  2021-05-12       Impact factor: 2.427

9.  Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis.

Authors:  Shirley Sze; Daniel Pan; Clareece R Nevill; Laura J Gray; Christopher A Martin; Joshua Nazareth; Jatinder S Minhas; Pip Divall; Kamlesh Khunti; Keith R Abrams; Laura B Nellums; Manish Pareek
Journal:  EClinicalMedicine       Date:  2020-11-12

Review 10.  The snapshot of metabolic health in evaluating micronutrient status, the risk of infection and clinical outcome of COVID-19.

Authors:  Dimitris Tsoukalas; Evangelia Sarandi; Spyridoula Georgaki
Journal:  Clin Nutr ESPEN       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.